ISO2025: Closing the Osteoporosis Care Gap: Key Insights for APPs

This session focuses on closing the osteoporosis care gap through primary and secondary fracture prevention strategies, with a particular emphasis on the critical role of Advanced Practice Providers (APPs).
ISO2025: How Interdisciplinary Teams work in Osteoporosis Care

This session highlights the critical role of interdisciplinary teams in effective osteoporosis care. The presenters explore how collaborative approaches, including Fracture Liaison Services and surgical optimization, improve patient outcomes and reduce fracture risk.
ISO2025: Rare Bone Disease

DESCRIPTION
ISO2025: Cancer and Bone Health

"This session addresses the complex relationship between cancer therapies and bone health, with a focus on hormone-related bone loss in breast and prostate cancer.
ISO2025: Getting Ahead of the Curve: Proactive Strategies for Osteoporosis Screening and Prevention

This session explores proactive, evidence-based strategies for osteoporosis screening and prevention, emphasizing a personalized, whole-health approach.
ISO2025: What is Frailty?

This session focuses on the intersection of frailty and osteoporosis in older adults, particularly within primary care settings. It highlights practical approaches to frailty assessment and personalized osteoporosis management to reduce fracture risk and improve functional outcomes.
ISO2025: Paget's Disease

This session examines the evolving landscape of Paget’s disease of bone, including its clinical presentation, epidemiology, and emerging insights into genetic and viral causes.
ISO2025: Long Term Treatment of the Osteoporosis Patient

This session provides a comprehensive overview of long-term osteoporosis treatment, emphasizing a lifetime approach to fracture prevention. Topics include optimal drug sequencing, transitioning between therapies, and strategies for maintenance to sustain bone health over time.
ISO2025: Advancing Osteoporosis Treatment: A Focus on Goal-Oriented Care

This session introduces a goal-directed approach to osteoporosis treatment, emphasizing individualized targets based on fracture risk and bone density. It explores how selecting and sequencing therapies—particularly anabolic agents—can optimize outcomes for patients at varying stages of risk.
ISO2025: Disparities and Bone Health

This session explores racial and ethnic disparities in osteoporosis screening, treatment, and outcomes. The presentation discusses contributing factors and outlines strategies for improving equity in bone health care delivery.